-
Parabilis Medicines targets up to $633.3M raise in upsized US IPO
-
Parabilis Medicines (PBLS) files for upsized 33.33 M share IPO at $17-$19/sh
-
Parabilis Medicines targets $475 million in U.S. IPO
-
Parabilis Medicines (PBLS) files for 25M share IPO at $17-$19/sh
-
Parabilis Medicines files for IPO to fund cancer drug development

